A Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-HU6
Clinical trial NCT06325930 · COMPLETED
Trial details
- NCT number
- NCT06325930
- Sponsor
- Rivus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-26
- Primary completion
- 2024-05-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.